Tristel plc
("Tristel" or the "Company")
Notice of investor presentation
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, confirms that its interim results for the six months ended 31 December 2020 will be announced on Monday 22 February 2021.
Due to physical distancing restrictions and to comply with UK Government directives to avoid non-essential travel, Tristel will not be hosting its usual shareholder investor presentations in the City, London. However, on Monday 22 February 2021 at 8am, a video presentation recorded by Paul Swinney, CEO and Liz Dixon, FD, will be made available here: www.tristelresults.com
If shareholders have any questions on the interim results for the Company's Management, please send them to tristel@walbrookpr.com and responses will be made available on the Company's website as soon as possible.
For further information please contact:
Tristel plc | Tel: 01638 721 500 | |
| Paul Swinney, Chief Executive Officer | | |
| Liz Dixon, Finance Director | | |
| | | |
| Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |
| Paul McManus | Mob: 07980 541 893 | |
| Lianne Cawthorne | Mob: 07584 391 303 | |
| | | |
| finnCap | Tel: 020 7220 0500 | |
| Geoff Nash/ Giles Rolls (Corporate Finance) | | |
| Alice Lane (ECM) |
| |
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
